Join to View Full Profile
600 Highland AveMadison, WI 53792
Phone+1 608-265-1700
Fax+1 608-266-6020
Dr. Uboha is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2012 - 2015- Yale-New Haven Medical CenterResidency, Internal Medicine, 2007 - 2010
Yale School of MedicineClass of 2007
Certifications & Licensure
WI State Medical License 2015 - 2025
CT State Medical License 2010 - 2015
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Safety of TAS-102 in Combination With Temozolomide for Metastatic Pancreatic NETs Start of enrollment: 2017 Aug 22
- Avelumab With Chemoradiation for Stage II/III Resectable Esophageal and Gastroesophageal Cancer Start of enrollment: 2018 May 29
- Abemaciclib and Pembrolizumab in Locally Advanced Unresectable or Metastatic Gastroesophageal Adenocarcinoma: Big Ten Cancer Research Consortium BTCRC-GI18-149 Start of enrollment: 2019 Aug 26
- Join now to see all
Publications & Presentations
PubMed
- Subclonal response heterogeneity to define cancer organoid therapeutic sensitivity.Jeremy D Kratz, Shujah Rehman, Katherine A Johnson, Amani A Gillette, Aishwarya Sunil
Scientific Reports. 2025-04-09 - Incorporating Circulating Tumor DNA Testing Into Clinical Trials: A Position Paper by the National Cancer Institute GI Oncology Circulating Tumor DNA Working Group.Lakshmi Rajdev, Gentry G King, Christopher H Lieu, Stacey A Cohen, Shubham Pant
JCO Precision Oncology. 2025-03-01 - 1 citationsOlaparib in treatment-refractory isocitrate dehydrogenase 1 (IDH1)- and IDH2-mutant cholangiocarcinoma: Safety and antitumor activity from the phase 2 National Cancer ...Michael Cecchini, Mary Jo Pilat, Nataliya Uboha, Nilofer S Azad, May Cho
Cancer. 2025-02-15
Lectures
- Phase I dose-escalation trial of trifluridine/tipiracil (TAS-102) and temozolomide in the treatment of advanced neuroendocrine tumors.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020
- Phase II study of the combination of abemaciclib and pembrolizumab in locally advanced unresectable or metastatic gastroesophageal adenocarcinoma: Big Ten Cancer Resea...ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
Press Mentions
TEVIMBRA Approved in U.S. For First-Line Treatment of Advanced Esophageal Squamous Cell Carcinoma in Combination with ChemotherapyMarch 4th, 2025- Clinical Scenarios and Approaches to Treating Locally Advanced Esophageal AdenocarcinomaAugust 28th, 2024
- Bispecific Antibodies in Gastric Cancer: Big Questions but Bigger Potential?August 26th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
